1. Home
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
Radiotherapy Market by Type, Technology, Procedure, Application, End User - Global Forecasts to 2027

Radiotherapy Market by Type, Technology, Procedure, Application, End User - Global Forecasts to 2027

  • August 2022
  • 295 pages
  • ID: 5226975
  • Format: PDF
  • MarketsandMarkets

Summary

Table of Contents

Search Inside

The global radiotherapy market is valued at USD 6.3 billion in 2022 and is expected to reach USD 8.1 billion by 2027, at a CAGR of 5.1% during the forecast period. Technological advancements in radiotherapy and the rising incidence of cancer are the major factors driving the growth of this market. Additionally, growing awareness of the benefits of radiotherapy and the increasing use of particle therapy for cancer treatment are other factors driving the growth of this market. However, inadequate healthcare infrastructure, especially in emerging countries and shortage of skilled oncologists and radiologists hinders the growth of this market. In addition to this, high cost of radiotherapy devices, and high complexities associated with radiotherapy treatment are the factors expected to restrain the growth of this market during the forecast period.

Theservice segment, by type, is expected to register the highest growth rate in the global radiotherapy market during the forecast period 2022-2027
Based on type, the radiotherapy market is segmented into products and services. In 2021, the products segment accounted for the largest market share while the service segment is forecasted to grow with a higher growth rate during 2022-2027.The service segment includes post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services. The service market segment is expected to register higher CAGR especially in matured markets like North America and Europe.

The Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators subsegment ofLinear Accelerators, within the external beam radiotherapy, to register a significant growth rateduring the forecast period
On the basis oftechnology, the radiotherapy market is segmented into external beam radiotherapy, internal beam radiotherapy/brachytherapy, and systemic radiotherapy products.The external beam radiotherapy products segment is further divided into linear accelerators, particle therapy systems, and conventional cobalt-60 teletherapy units.

The internal beam radiotherapy/brachytherapy products segment includes seeds, applicators, afterloaders, and IORT systems.The linear accelerators or LINAC segment is further characterized by conventional LINAC systems and stereotactic advanced electron/cobalt-60 LINAC systems.

The Stereotactic advanced LINAC systems segment is expected to register the highest growth rate amongst linear accelerators segment.These systems provide precise 3D localization of the treatment target for various oncology procedures.

The major objective of advanced LINAC systems is to expose the tumor to a single high dose of radiation while minimizing exposure to healthy surrounding structures. These systems can provide high precision and reduced treatment time with real-time tracking features which further supports the adoption of these systems.

Continuous product development and launchesto drive the segment growthof particle therapy technology segment
Based on technology, the radiotherapy market has been segmented into external beam radiotherapy and internal beam radiotherapy.The particle therapy subsegment of external beam radiotherapy is expected to grow with the highest growth rate amongst other segments of external beam radiotherapy (including linear accelerators, and conventional cobalt-60 teletherapy units).

Continuous product development and R&D activities are also driving the growth of this market segment.Several particle therapy products have been launched in the market in the last three years.

For example, Varian Medical Systems, Inc. (US), now under Siemens Healthineers AG (Germany), launched the ProBeam 360° single-room proton therapy system in 2018 and introduced a multi-room configuration for the same product in 2019. In April 2020, P-Cure (Israel) received CE marking for the P-ARTIS System, enabling the company to market and sell the product in Europe.

The China market, by region, is expected to grow with the highest growth rate in the global rdaiotherpay market during the forecast period of 2022-2027
On the basis of region, the radiotherapy market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.The Asia Pacific held the third largest share of the global radiotherapy market in 2021.

Within Asia Pacific, China is expected to grow with the highest CAGR during the forecast period.The growth of this market is primarily driven by the favorable healthcare reforms and investments in the country.

Owing to the growth potential of the Chinese radiotherapy market, various players are undertaking strategic initiatives to strengthen their presence in the country. These players include Mevion Medical Systems, IBA, Accuray, and Varian, which entered into partnerships, licensing deals, agreements, and cooperation framework agreements with various end users and stakeholders in China, to increase market presence in the country..

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type:Tier 1–30%, Tier 2–42%, and Tier 3– 28%
• By Designation: C-level–10%, Director-level–76%, and Others–14%
• By Region:North America–40%, Europe–30%, Asia Pacific–22%, Latin America–6%, and the Middle East & Africa–2%

The dominant players in the global radiotherapy market are Siemens Healthineers AG (Germany), Elekta (Sweden) Accuray Incorporated (US), IBA (Belgium), ViewRay Technologies, Inc. (US), Hitachi Ltd. (Japan), iCAD, Inc. (US), IsoRay, Inc. (US), Mevion Medical Systems, Inc. (US), Panacea Medical Technologies Pvt. Ltd. (India), P-cure Ltd. (Israel), and ZEISS Group (Germany), among others.

Research Coverage
This report studies the radiotherapymarket based ontype, technology, procedure, application, end user, and region.It also coversthe factors affecting market growth,analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders.

Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:
• Market Penetration:Comprehensive information on the product portfolios offered by the top players in the radiotherapymarket
• Product Development/Innovation:Detailed insights on the upcoming trends, R&D activities, and product launches in the radiotherapymarket
• Market Development:Comprehensive information on lucrative emerging regions
• Market Diversification:Exhaustive information about new products, growing geographies, and recent developments in the radiotherapymarket
• Competitive Assessment:In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Asparaginase Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Application, End-Use Industry, and Geography

  • $ 4550
  • August 2022
  • 176 pages

The global asparaginase market is expected to grow from US$ 564.01 million in 2021 to US$ 1,575.62 million by 2028. It is expected to grow with a CAGR of 16.1% from 2022 to 2028. The rising incidence ...

  • World
  • Cancer
  • Healthcare
  • Industry analysis
  • Cancer Incidence
  • Health Expenditure

ref:plp2022

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on